Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Change in Cash came in at -$56.7 million in Q4 2025, down 8418.47% year-on-year from $682012.6 in Q4 2024, and down 178.16% quarter-over-quarter from -$20.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Cash history runs 16 years deep, the most recent figure standing at -$56.7 million for Q4 2025.
- On a quarterly basis, Change in Cash fell 8418.47% year-over-year to -$56.7 million in Q4 2025; TTM through Dec 2025 was $11.5 million, a 190.25% increase from a year earlier, with the FY2025 full-year figure at $51.4 million, up 527.75% from the prior year.
- Change in Cash eased to -$56.7 million in Q4 2025 per PBH's latest filing, from -$20.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $131.3 million in Q2 2021 and bottomed at -$120.8 million in Q3 2021.
- The 5-year median for Change in Cash is $1.4 million (2023), against an average of $13500.0.
- Across the five-year window, Change in Cash soared 456.67% in 2021 and sank 8418.47% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$21.8 million in 2021, then soared by 301.45% to $43.9 million in 2022, then slumped by 91.92% to $3.5 million in 2023, then sank by 118.77% to -$666000.0 in 2024, then sank by 8418.47% to -$56.7 million in 2025.
- Per Business Quant, the three latest PBH Change in Cash figures stand at -$56.7 million (Q4 2025), -$20.4 million (Q3 2025), and $41.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn | -56.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -56.73 Mn |
| Sep 30, 2025 | -20.40 Mn |
| Jun 30, 2025 | 41.62 Mn |
| Mar 31, 2025 | 47.01 Mn |
| Dec 31, 2024 | -666,000.00 |
| Sep 30, 2024 | 17.28 Mn |
| Jun 30, 2024 | -12.21 Mn |
| Mar 31, 2024 | -17.15 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 5.49 Mn |
| Jun 30, 2023 | -3.91 Mn |
| Mar 31, 2023 | -27.87 Mn |
| Dec 31, 2022 | 43.92 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 8.68 Mn |
| Mar 31, 2022 | 6.17 Mn |
| Dec 31, 2021 | -21.80 Mn |
| Sep 30, 2021 | -120.81 Mn |
| Jun 30, 2021 | 131.32 Mn |
| Mar 31, 2021 | -29.80 Mn |